At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GSK GlaxoSmithKline PLC
Closed 12-22 16:00:00 EST
48.59
-0.02
-0.04%
盘后48.48
-0.11-0.22%
19:56 EST
High48.88Low48.50Vol2.60M
Open48.65D1 Closing48.61Amplitude0.78%
Mkt Cap99.02BTradable Cap94.60BTotal Shares2.04B
T/O126.60MT/O Rate0.13%Tradable Shares1.95B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

U.S. Pressure Clouds GSK's Outlook -- Market Talk
Dow Jones  ·  12-22 19:39
U.S. Pressure Clouds GSK's Outlook -- Market Talk
Merck (MRK.US), Bristol-Myers Squibb (BMY.US), and Other Pharma Giants Agree to Lower U.S. Drug Prices in Exchange for Tariff Exemptions and Policy Support
Stock News  ·  12-20
Merck (MRK.US), Bristol-Myers Squibb (BMY.US), and Other Pharma Giants Agree to Lower U.S. Drug Prices in Exchange for Tariff Exemptions and Policy Support
Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies
MT Newswires Live  ·  12-20
Trump Reportedly Strikes Drug Price Deals With 9 Pharma Companies
Trump: the 3 of the 17 Pharmaceutical Companies Who Have Not Agreed Are Coming in Next Week
THOMSON REUTERS  ·  12-20
Trump: the 3 of the 17 Pharmaceutical Companies Who Have Not Agreed Are Coming in Next Week
Companies Agree to Sell All Future Drugs at Most Favored Nation Prices -U.S. Official
THOMSON REUTERS  ·  12-20
Companies Agree to Sell All Future Drugs at Most Favored Nation Prices -U.S. Official
14 of 17 Leading Drug Manufacturers NOW Part of Trump Administration’s Most Favored Nation Initiative -U.S. Official
THOMSON REUTERS  ·  12-20
14 of 17 Leading Drug Manufacturers NOW Part of Trump Administration’s Most Favored Nation Initiative -U.S. Official
Companies Will Offer Many Drugs Direct-to Consumer at Lower Prices Through Trumprx Website -U.S. Official
THOMSON REUTERS  ·  12-20
Companies Will Offer Many Drugs Direct-to Consumer at Lower Prices Through Trumprx Website -U.S. Official
Deals Are With Amgen, Bristol Myers Squibb, Roche’s Genentech, Gilead, GSK, Merck, Novartis, Sanofi and Boehringer Ingelheim -U.S. Official
THOMSON REUTERS  ·  12-20
Deals Are With Amgen, Bristol Myers Squibb, Roche’s Genentech, Gilead, GSK, Merck, Novartis, Sanofi and Boehringer Ingelheim -U.S. Official
Trump to Announce Deals With Nine Pharmaceutical Companies to Reduce Drug Prices -Senior Administration Official
THOMSON REUTERS  ·  12-20
Trump to Announce Deals With Nine Pharmaceutical Companies to Reduce Drug Prices -Senior Administration Official
at Least Seven Drug Companies Are Set to Announce Price Cuts With Trump at White House on Friday, Including Glaxosmithkline, Merck and Sanofi - Wapo
THOMSON REUTERS  ·  12-20
at Least Seven Drug Companies Are Set to Announce Price Cuts With Trump at White House on Friday, Including Glaxosmithkline, Merck and Sanofi - Wapo
GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst
Benzinga_recent_news  ·  12-19
GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
GlobeNewswire  ·  12-19
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
GSK Falls Thursday, Underperforms Market
Dow Jones  ·  12-19
GSK Falls Thursday, Underperforms Market
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
GlobeNewswire  ·  12-18
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
GSK gets EU regulator backing for expanded use of RSV vaccine
Reuters  ·  12-12
GSK gets EU regulator backing for expanded use of RSV vaccine
RPT-UPDATE 2-US FDA expands use of GSK's Blujepa as treatment for gonorrhea
Reuters  ·  12-12
RPT-UPDATE 2-US FDA expands use of GSK's Blujepa as treatment for gonorrhea
GSK Says Risvutatug Rezetecan Gets FDA Orphan Drug Designation For Small-Cell Lung Cancer Treatment
MT Newswires Live  ·  12-10
GSK Says Risvutatug Rezetecan Gets FDA Orphan Drug Designation For Small-Cell Lung Cancer Treatment
GSK Forms Collaboration With Oxford BioTherapeutics to Discover Antibody-Based Cancer Treatments
MT Newswires Live  ·  12-10
GSK Forms Collaboration With Oxford BioTherapeutics to Discover Antibody-Based Cancer Treatments
GSK Slips Tuesday, Underperforms Market
Dow Jones  ·  12-10
GSK Slips Tuesday, Underperforms Market
Is GSK’s Exit and IDE034’s FDA Green Light Reframing the Investment Case For IDEAYA Biosciences (IDYA)?
Simply Wall St.  ·  12-09
Is GSK’s Exit and IDE034’s FDA Green Light Reframing the Investment Case For IDEAYA Biosciences (IDYA)?

Introduction

Company Name.
GlaxoSmithKline PLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Issue price:
--